Routine blood testing for "Forever Chemicals": implications of the 2022 NASEM PFAS report recommendations

References

• National Academies of Sciences, Engineering, and Medicine. Guidance on PFAS exposure, testing, and clinical follow-Up. Washington, DC: The National Academies Press; 2022. doi:10.17226/26156.
   Google Scholar
• Steenland K, Fletcher T, Stein CR, et al. Review: evolution of evidence on PFOA and health following the assessments of the C8 science panel. Environ Int. 2020;145:106125. doi:10.1016/j.envint.2020.106125.
   PubMed Web of Science ®Google Scholar
• Zahm S, Bonde JP, Chiu WA, et al. Carcinogenicity of perfluorooctanoic acid and perfluorooctanesulfonic acid. Lancet Oncol. 2024;25(1):16–17. doi:10.1016/S1470-2045(23)00622-8.
   PubMed Web of Science ®Google Scholar
• Hölzer J, Lilienthal H, Schümann M. Human biomonitoring (HBM)-I values for perfluorooctanoic acid (PFOA) and perfluorooctane sulfonic acid (PFOS) – description, derivation and discussion. Regul Toxicol Pharmacol. 2021;121:104862. doi:10.1016/j.yrtph.2021.104862.
   PubMedGoogle Scholar
• Schümann M, Lilienthal H, Hölzer J. Human biomonitoring (HBM)-II values for perfluorooctanoic acid (PFOA) and perfluorooctane sulfonic acid (PFOS) – description, derivation and discussion. Regul Toxicol Pharmacol. 2021;121:104868. doi:10.1016/j.yrtph.2021.104868.
   PubMedGoogle Scholar
• Kwiatkowski CF, Andrews DQ, Birnbaum LS, et al. Scientific basis for managing PFAS as a chemical class. Environ Sci Technol Lett. 2020;7(8):532–543. doi:10.1021/acs.estlett.0c00255.
   PubMed Web of Science ®Google Scholar
• Power M, Fell G, Wright M. Principles for high-quality, high-value testing. Evid Based Med. 2013;18(1):5–10. doi:10.1136/eb-2012-100645.
   PubMedGoogle Scholar
• Koch C, Roberts K, Petruccelli C, et al. The frequency of unnecessary testing in hospitalized patients. Am J Med. 2018;131(5):500–503. doi:10.1016/j.amjmed.2017.11.025.
   PubMed Web of Science ®Google Scholar
• Stewart J, McCallin T, Martinez J, et al. Hyperlipidemia. Pediatr Rev. 2020;41(8):393–402. doi:10.1542/pir.2019-0053.
   PubMed Web of Science ®Google Scholar
• Barry MJ, Nicholson WK, Silverstein M, et al. Screening for lipid disorders in children and adolescents: US preventive services task force recommendation statement. JAMA. 2023;330(3):253–260. doi:10.1001/jama.2023.11330.
   PubMed Web of Science ®Google Scholar
• Bibbins-Domingo K, Grossman DC, Curry SJ, et al. Screening for thyroid cancer: US preventive services task force recommendation statement. JAMA. 2017;317(18):1882–1887. doi:10.1001/jama.2017.4011.
   PubMed Web of Science ®Google Scholar
• Godbole NP, Koester M, Marcus EN. Hypothyroidism in adult women: the utility of targeted vs universal thyroid screening. Int J Womens Health. 2023;15:1515–1522. doi:10.2147/IJWH.S397129.
   PubMed Web of Science ®Google Scholar
• Werhun A, Hamilton W. Thyroid function testing in primary care: overused and under-evidenced? A study examining which clinical features correspond to an abnormal thyroid function result. Fam Pract. 2015;32(2):187–191. doi:10.1093/fampra/cmv010.
   PubMed Web of Science ®Google Scholar
• Wintemute K, Greiver M, McIsaac W, et al. Choosing Wisely Canada campaign associated with less overuse of thyroid testing: retrospective parallel cohort study. Can Fam Physician. 2019;65(11):e487–e496.
   PubMed Web of Science ®Google Scholar
• Calonge N, Bibbins-Domingo K, Cantu AG, et al. Screening for testicular cancer: U.S. Preventive services task force reaffirmation recommendation statement. Ann Intern Med. 2011;154(7):483–486.doi:10.7326/0003-4819-154-7-201104050-00006.
   PubMed Web of Science ®Google Scholar
• Frequently Asked Questions. C-8 Medical Monitoring Program. 2023; [cited 2023]. Available from: http://www.c-8medicalmonitoringprogram.com/faq.
   Google Scholar
• O’Brien J. Panel introduces medical monitoring plan in C8 case. West Virginia Record; 2013 [cited 2023]. Available from: https://wvrecord.com/stories/510605139-panel-introduces-medical-monitoring-plan-in-c8-case.
   Google Scholar
• Usher-Smith J, Simmons RK, Rossi SH, et al. Current evidence on screening for renal cancer. Nat Rev Urol. 2020;17(11):637–642. doi:10.1038/s41585-020-0363-3.
   PubMed Web of Science ®Google Scholar
• Rossi SH, Hsu R, Blick C, et al. Meta-analysis of the prevalence of renal cancer detected by abdominal ultrasonography. Br J Surg. 2017;104(6):648–659. doi:10.1002/bjs.10523.
   PubMed Web of Science ®Google Scholar
• Bangma CH, Loeb S, Busstra M, et al. Outcomes of a bladder cancer screening program using home hematuria testing and molecular markers. Eur Urol. 2013;64(1):41–47. doi:10.1016/j.eururo.2013.02.036.
   PubMed Web of Science ®Google Scholar
• Bolenz C, Schröppel B, Eisenhardt A, et al. The investigation of hematuria. Dtsch Arztebl Int. 2018;115(48):801–807. doi:10.3238/arztebl.2018.0801.
   PubMed Web of Science ®Google Scholar
• Sugimura K, Ikemoto SI, Kawashima H, et al. Microscopic hematuria as a screening marker for urinary tract malignancies. Int J Urol. 2001;8(1):1–5. doi:10.1046/j.1442-2042.2001.00235.x.
   PubMed Web of Science ®Google Scholar
• Hiatt RA, Ordoñez JD. Dipstick urinalysis screening, asymptomatic microhematuria, and subsequent urological cancers in a population-based sample. Cancer Epidemiol Biomarkers Prev. 1994;3(5):439–443.
   PubMed Web of Science ®Google Scholar
• Khadra MH, Pickard RS, Charlton M, et al. A prospective analysis of 1,930 patients with hematuria to evaluate current diagnostic practice. J Urol. 2000;163(2):524–527. doi:10.1016/S0022-5347(05)67916-5.
   PubMed Web of Science ®Google Scholar
• Barocas DA, Boorjian SA, Alvarez RD, et al. Microhematuria: AUA/SUFU guideline. J Urol. 2020;204(4):778–786. doi:10.1097/JU.0000000000001297.
   PubMed Web of Science ®Google Scholar
• Brenner DJ, Hall EJ. Computed tomography–an increasing source of radiation exposure. N Engl J Med. 2007;357(22):2277–2284. doi:10.1056/NEJMra072149.
   PubMed Web of Science ®Google Scholar
• United States Census Bureau. Census Bureau Releases New 2020 Census Data on Age, Sex, Race, Hispanic Origin. Households and Housing; 2023; [cited 2024]. Available from: https://www.census.gov/newsroom/press-releases/2023/2020-census-demographic-profile-and-dhc.html.
   Google Scholar
• Bottinor W, Polkampally P, Jovin I. Adverse reactions to iodinated contrast media. Int J Angiol. 2013;22(3):149–154. doi:10.1055/s-0033-1348885.
   PubMedGoogle Scholar
• Poslusny C. How much does a CT scan cost? New Choice Health; 2023; [cited 2023]. Available from: https://www.newchoicehealth.com/ct-scan/cost.
   Google Scholar
• Risk Management for Per- and Polyfluoroalkyl Substances (PFAS) under TSCA. US Environmental Protection Agency; 2024; [cited 2024]. Available from: https://www.epa.gov/assessing-and-managing-chemicals-under-tsca/risk-management-and-polyfluoroalkyl-substances-pfas.
   Google Scholar